A Randomized, Controlled Trial to Determine Whether Continued Ribavirin Monotherapy in Hepatitis C Virus–Infected Patients Who Responded to Interferon‐Ribavirin Combination Therapy Will Enhance Sustained Virologic Response

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Sustained Virologic Response ◽

Controlled Trial ◽

Virologic Response ◽

A randomized, controlled trial to determine if continuing ribavirin (RVN) as monotherapy following interferon/ribavirin (IFN/RVN) combination therapy will increase sustained virologic response in patients with chronic HCV

Gastroenterology ◽

10.1016/s0016-5085(00)85927-2 ◽

2000 ◽

Vol 118 (4) ◽

pp. A946 ◽

Cited By ~ 1

Author(s):

Charlotte M. Hofmann ◽

Richard K. Sterling ◽

Velimir A. Luketic ◽

Arun J. Sanyal ◽

Mitchell L. Shiffman

Keyword(s):

Combination Therapy ◽

Sustained Virologic Response ◽

Controlled Trial ◽

Virologic Response ◽

Randomized Controlled ◽

Chronic Hcv

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

Liver Transplantation ◽

10.1002/lt.22271 ◽

2011 ◽

Vol 17 (5) ◽

pp. 528-538 ◽

Cited By ~ 82

Author(s):

Natalie Bzowej ◽

David R. Nelson ◽

Norah A. Terrault ◽

Gregory T. Everson ◽

Lichen L. Teng ◽

...

Keyword(s):

Liver Transplantation ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Prophylactic Treatment ◽

Controlled Trial ◽

Randomized Controlled ◽

Peginterferon Alfa

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis

Arthritis & Rheumatism ◽

10.1002/art.34322 ◽

2012 ◽

Vol 64 (3) ◽

pp. 835-842 ◽

Cited By ~ 146

Author(s):

Michael C. Sneller ◽

Zonghui Hu ◽

Carol A. Langford

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Controlled Trial ◽

Cryoglobulinemic Vasculitis ◽

Treatment of hepatitis C virus-related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment

Hepatology ◽

10.1002/hep.510290616 ◽

1999 ◽

Vol 29 (6) ◽

pp. 1870-1875 ◽

Cited By ~ 154

Author(s):

Dominique-Charles Valla ◽

Michele Chevallier ◽

Patrick Marcellin ◽

Jean-Louis Payen ◽

Christian Trepo ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Interferon Alfa ◽

Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trial

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2005.00575.x ◽

2005 ◽

Vol 12 (1) ◽

pp. 58-66 ◽

Cited By ~ 16

Author(s):

M. Wright ◽

D. Forton ◽

J. Main ◽

R. Goldin ◽

E. Torok ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Controlled Trial ◽

Hepatitis C Virus Infection ◽

Epoetin Alfa Once Weekly Improves Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated With Interferon/Ribavirin: A Randomized Controlled Trial

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/01.qai.0000167158.90722.73 ◽

2005 ◽

Vol 39 (4) ◽

pp. 504-506 ◽

Cited By ~ 24

Author(s):

Mark S Sulkowski ◽

Douglas T Dieterich ◽

Edmund J Bini ◽

Norbert Br??u ◽

Daniel Alvarez ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Epoetin Alfa ◽

Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis

Internal Medicine ◽

10.2169/internalmedicine.9671-17 ◽

2018 ◽

Vol 57 (7) ◽

pp. 951-956 ◽

Cited By ~ 4

Author(s):

Haruki Uojima ◽

Shuko Murakami ◽

Seigo Nakatani ◽

Hisashi Hidaka ◽

Atsuko Takeuchi ◽

...

Keyword(s):

Liver Cirrhosis ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Sustained Virologic Response ◽

Virologic Response ◽

Late Relapse ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Faculty Opinions recommendation of Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718025097.793482339 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Genotype 1 ◽

Virus Genotype ◽

Randomized Controlled ◽

Treatment Naïve ◽

Peginterferon Alfa

Faculty Opinions recommendation of Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718025097.793482741 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Genotype 1 ◽

Virus Genotype ◽

Randomized Controlled ◽

Treatment Naïve ◽

Peginterferon Alfa

Faculty of 1000 evaluation for Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718056513.793482341 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Controlled Trial ◽

Pegylated Interferon ◽

Hepatitis C Virus Infection ◽